Process for preparing optically active epoxides

Information

  • Patent Grant
  • 6693205
  • Patent Number
    6,693,205
  • Date Filed
    Friday, January 10, 2003
    21 years ago
  • Date Issued
    Tuesday, February 17, 2004
    20 years ago
Abstract
The invention concerns a process for the production of optically active epoxides useful as pharmaceutical intermediates, particularly in the field of HIV protease inhibitors. The optically active epoxides are produced in commercially acceptable yields from an optically active alcohols by a Mitsunobu reaction and a cyclisation step, preferably comprising an intermediate re-crystallisation step. The stereochemistry of the alcohol is inverted during the Mitsunobu reaction to produce the desired epoxide.
Description




This application is a 371 of PCT/GB01/04146 filed Sep. 18, 2001.




BACKGROUND OF THE INVENTION




Field of the Invention




The present invention concerns a process for producing optically active epoxides, particularly those epoxides which are useful as pharmaceutical intermediates




There are a number of potential pharmaceutical products which contain the following optically active grouping:











The enantiomer (2S, 3R) of this grouping may also be useful in pharmaceutical compounds. The grouping is derivable from the epoxide of equivalent stereochemistry, in the case of the (2R, 3S)-grouping, the (2R, 3S)-epoxide:











where Boc is a butoxycarbonyl amine protecting group.




SUMMARY OF THE INVENTION




EP-A-0885879 describes a process for producing optically active cyanohydrins, particularly an optically active N-(protected)-3-amino-2-hydroxy-4-phenylbutyronitrile which comprises treating a mixture of diastereomers of an N-protected)-3-amino-2-bydroxy-4-Aphenylbutyronitrile in the presence of an amine and an organic solvent. The optically active compound is said to be an intermediate in the production of certain pharmaceutical compounds.




EP-A-0934923 describes a method for producing optically active erythro-3-amino-2-hydroxybutyric esters comprising oxidising the hydroxyl group at the 2-position of an optically active (at the 3-position) 3-amino-2-hydroxybutyric ester and then reducing erythro-selectively the resulting product using alubnum alkoxide. The resulting optically active compound is said to be a pharmaceutical intermediate, specifically for HIV protease inhibitors.




WO-A-99/38855 describes a process for producing optically active threo-3-amino-1,2-epoxy compounds comprising subjecting an optically active threo-3-amino-1,2-diol to allkylsulphonylation or arylsulphonylation in an organic solvent in the presence of a base to give the corresponding optically active threo-3-amino-2-hydroxy-1-sulphonyloxy compound and subjecting the resulting compound to epoxidation in the presence of a base to give the corresponding optically active threo-3-amino-1,2-epoxy compound.




WO-A-00/10986 describes a process for the preparation of (2R,3S)-3-amino-1,2-oxirane comprising treating a (2S,3S)-3-amino-1-halo-2-hydroxy-4-phenylbutane or a (2S,3S3-amino-4-phenylbutane-1,2-epoxide either with a quaternary ammonium carboxylate or with both a metal carboxylate and a quaternary ammonium salt to prepare a (2S,3S)-1-acyloxy-3-amino-2-hydroxy-4-phenylbutane, treating this compound with a sulphonyl halide in the presence of an organic base to prepare a (2S,3S)-1-acyloxy-3-amino-2-sulphonyloxy-4 phenylbutane and subjecting the compound thus obtained to treatment with an inorganic base. It is said that this process allows the production of intermediates for HIV protease inhibitors using L-phenylalanine as a raw material.




U.S. Pat. No. 5,936,104 describes a process for producing (2S,3S)- or (2R,3R)-1,2epoxy-3-amino-4phenylbutane derivatives comprising treating a 1-halo-2-hydroxy-3-amino-4-phenylbutane derivative with a base in an aprotic polar organic solvent or a mixed solvent composed of an aprotic polar organic solvent and water and then causing the resulting epoxide to crystallise out from a mixed solvent composed of an aprotic polar organic solvent and water. The resulting compound is said to be useful as an intermediate in the production of various HIV protease inhibitors as described, for example, in Japanese Kokai Publication Hei-08-109131.




WO-A-95/08530 describes a process for producing 3-amino-2-hydroxy-1-propanol derivatives which are said to be useful as intermediates in the production of medicines.




JP9323960 describes a method for obtaining 3-amino-1,2-oxirane by using a 3-amino-1,2-diol as a raw material. The process comprises reacting an N-(protected)-3-amino-1,2-diol with an orthoacetate or orthoformate in the presence of an acid catalyst to form an alkoxyalkylidene. The alkoxyalkylidene is reacted with a halogenating agent to form an alkoxy halide which is then treated with a base and converted to an epoxide, thus obtaining the 3-amino-1,2-oxirane.




WO-A-97/42180 describes a process for preparing oxiranemethanamine derivatives, which are said to be usefull as intermediates for preparing aspartyl protease inhibitors, comprising the steps of activating an aminodiol, acylating the aminodiol and reacting the acylated aminodiol with a base to form an epoxy compound.




The processes and methods described in these documents all suffer from one or more of the following disadvantages: they do not describe methods of synthesising 2R,3S-epoxides or their enantiomers; their stereochemistry is unclear; they use expensive or difficult to obtain reagents; they describe complex reaction procedures with numerous stages; they describe low product yields; the products described are insufficiently pure for use as pharmaceutical intermediates; they relate to laboratory scale processes and are of unproven or uncertain value on a commercial scale; or they are commercially unattractive for other reasons.




The academic literature describes various methods of synthesising 2R,3S-epoxides but these also suffer from one or more of the aforesaid disadvantages or disclose mixtures of epoxides with other stereoisomers. Examples of such academic literature include Ojima et al, Tetrahedron Letters 39 (1998) 923-926; Barrish et al, J. Med.Chem. 1994, 37, 1758-1768; Romeo and Rich, Tetrahedron Letters, 35 (1994) 4939-4942; Luly et al, J.Org.Chem. 1987, 52, 1487-1492; Evans et al, J.Org.Chem. 1985, 50,4615-4625 and Parkes et al, J.Org.Chem. 1994, 59, 3656-3664.




Other attempts to find commercially acceptable routes to the 2S,3S- and 2R,3S-epoxides have been made recently by Malik, whose work in this respect was detailed at the 3rd International Conference “Organic Process Research and Development” organised by Scientific Update on 10-12 July 2000. However, the yields for individual steps described are poor (about 53%) and toxic and/or expensive chemicals, such as cesium acetate and 18-crown ether, are used.




There remains a need in the art for an improved process for the production of optically active epoxide pharmaceutical intermediates.




According to the present invention there is provided a process for producing an optically active (2R, 3S)-epoxide of the general formula (1):











or its enantiomer wherein each of R


1


and R


2


is independently selected from hydrogen, optionally substituted alkyl, aryl, aralkyl or alkaryl groups, and amine-protecting groups and R


3


is selected from hydrogen and optionally suitably protected alkyl, cycloalky, aryl, aralkyl or alkal groups which comprises conducting a Mitsunobu reaction on an optically active (2S,3S)-alcohol of general formula (2):











or its enantiomer wherein X is a leaving group and R


1


, R


2


and R


3


are the same as the corresponding R


1


, R


2


and R


3


in formula (1) and cyclising the resulting Mitsunobu product




DESCRIPTION OF THE PREFERRED EMBODIMENTS




The Mitsunobu process has been known since 1967 (Mitsunobu and Yamada in M.Bull.Chem.Soc.JPN. 1967, 40, 2380-2382) and was later described in 1991, the general reference being Mitsunobu, Synthesis, 1981, 1-28. This document described intermolecular dehydration reactions between alcohols and acidic components on treatment with diethyl azodicarboxylate and triphenylphosphine in which virtually complete inversion of the configuration of the alcoholic hydroxy group takes place. The Mitsunobu process was reviewed by Hughes, Org.Reac. 1992, 42, 335. Mechanistic studies of Mitsunobu chemistry have been described by Camp and Jenkins in J.Org.Chem. 1989, 54, 3045-3049, Varasi et al in J.Org.Chem. 1987, 52, 4235-4238 and Hughes et al in J.Am.Chem.Soc 1988, 110, 6487-649. The effect of the acidic component in Mitsunobu chemistry has been described by Martin and Dodge in Tetrahedron Letters, 1991, Vol. 32 No. 26, pages 3017-3020, by Dodge et al in J.Org.Chem. 1994, 59, 234-236 and by Hughes and Reamer in J.Org.Chem. 1996, 61, 2967-2971. Examples of industrial processes utilising Mitsunobu chemistry are described by Thomas et al in Organic Process Research and Development 1997, 1, 294-299 and by Marzoni et al in Synthetic Communications, 25 (16), 2475-2482 (1995). Reference to the use of a Mitsunobu reaction for the synthesis of substituted piperazinones can be found in WO-A-00/01678.




A preferred process according to the invention, comprises recrystallising the Mitsunobu reaction product prior to cyclising. R


3


is preferably a group selected from hydrogen and optionally substituted alkyl, cycloaukyl, aryl, arallcyl and alkaryl groups. The group is preferably protected where it contains free oxygen, nitrogen or sulphur, which may react with reagents used in the Mitsunobu reaction.




The leaving group X is any suitable leaving group and is preferably selected from halogens, sulphonate esters and trialkyl ammonium groups.




One reaction scheme according to the invention may be summarised as follows:











Estenification Step




The esterification step preferably comprises treating the compound of formula (2) with a phosphine and an azodicarboxylate under acid conditions to form an intermediate ester of formula (3):











wherein X, R


1


, R


2


and R


3


are the same as the corresponding X, R


1


, R


2


and R


3


in formula (2) and R


4


is an optionally nitrogenated alkyl, aryl, aralkyl or alkaryl group.




Suitable phosphines include trialkyl- and triaryl phosphines such as triphenylphosphine, tributylphosphine and methyldiphenylphosphine. Triphenylphosphine is preferred. Polymer bound triphenylphosphine as disclosed in J. Org. Chem, 1983, 48, 3598 may also be used, as may bis(diphenylphosphine)ethane disclosed in Tetrahedron Letters, 1998, 39, 7787.




Suitable azodicarboxylates include diisopropylazodicarboxylate (DIAD), diethylazodicarboxylate (DEAD) and di-tert-butylazodicarboxylate (DTBA). DIAD is preferred.




Suitable acids include carboxylic acids such as acetic acid, trifluoroacetic acid and para-nitrobenzoic acid (PNBA). PNBA is preferred.




Suitable solvents for the esterification are aprotic solvents including benzene, toluene, chlorinated hydrocarbons, ethyl acetate and water miscible solvents including tetrahydrofuran, dimethoxyethane and dioxane. Toluene and tetrahydrofuran are preferred. Suitable solvents for crystalisation of the esterified product include low boiling alcohols, optionally in admixture with water. Ethanol/water mixtures are preferred.




Recrystallisation Step




The recrystallisation step is preferably effected from an ethanol/water mixture and is conducted to remove minor contaminants of triphenylphosphineoxide, DIAD-H2 and of 2S,3S-ester from the 2R,3S-ester (or 2R, 3R-ester from the 2S, 3R-ester in the enantiomerically equivalent process of the invention).




Cyclisation Step




The cyclisation step preferably comprises treating the recrystallised intermediate ester with an aqueous base. Suitable bases include alkali and alkaline earth metal hydroxides and quaternary ammonium or phosphonium compounds. The 2R,3S-ester intermediate can be saponified and cyclised by, for example, working up in ethanol and an aqueous base such as potassium hydroxide. Phase transfer conditions can also be employed using an aqeuous base, a water immiscible solvent, such as toluene or a chlorinated hydrocarbon, and a suitable catalyst, such as a quaternary ammonium or phosphonium salt.




The alcohol of formula (2) may be obtained by known routes (e.g. J. Org. Chem. 1994, 59, 3656) from amino acids and synthetic amino acids. One preferred starting material for obtaining the 2R, 3Sepoxide is L-phenylalanine. A preferred starting material for obtaining the 2S, 3R-epoxide is D-phenylalanine. In the process of the invention, the alcohol is preferably a haloalcohol, even more preferably a chloroalcohol.




The amine protecting group is preferably butoxycarbonyl or benzyloxycarbonyl.











The invention will now be more parxicularly described with reference to the following examples.




EXAMPLE 1




A 3 (protected) amino4-phenyl-1-chlorobutan-2-ol was esterified according to the following reaction scheme:





























Reagents




























100%










Reagents




Mass




Strength




Strength




MW




Moles




Eq.




Source





















2S,3S chloroalcohol




30.0 g




96.9%




29.1 g




300




0.097




1.0×




Synthesised according








2S,3S








to J. Org. Chem.













1994, 59, 3656






DIAD




24.6 g




95%




23.4 g




202




0.116




1.2×




Aldrich













PO 06304DR






Triphenylphosphine (TPP)




30.6 g




99%




30.3 g




262




0.116




1.2×




Aldrich













60707009






p-Nitrobenzoic acid




20.2 g




98%




19.8 g




167




0.119




1.2×




Aldrich






(PNBA)










07117HU






Toluene




1200 ml




>99%




1200 ml




92














BDH 30454






Ethanol




450 ml




Absolute




450 ml




85














Hays DEB100






Water




180 ml




Towns




180 ml




18














Towns






Ethanol/Water




100 ml




Absolute/




1:1



















Hays DEB 100/








Towns








Towns














Procedure




A 2L flange necked flask was equipped with an overhead mechanical stirrer (paddle), thermometer, pressure equalised dropping funnel and nitrogen blanket. The flask was charged with 30.0 g of the chloroalcohol of formula (2) and 1200 ml of toluene to form a slurry. 30.6 g of TPP and 20.2 g of PNBA were then added and the mixture stirred at 18-20° C. 24.6 g of DIAD was dripped into the flask over a 5 min period, resulting in an exotherm to 25° C. Once all the DIAD had been added, stirring was continued for 2 hr to give a yellow solution. This solution was transferred to a rotary evaporator and the bulk of the toluene was distilled at approximately 100 mbar and 60° C. The residual yellow oil was taken up in 450 ml of ethanol and the solution was heated to 70° C. 180 ml of water were added in portions maintaining a temperature of >65° C. Care was taken, by means of gradual addition of the water over ten minutes, during water addition to prevent oiling of the product. The solution was cooled to 50° C. and seeded with product to induce crystallisation. The slurry was cooled to 10° C. with the bulk of the product crystallising at 45-50° C. The product was filtered through Whatman 54 paper and the cake was washed with 100 ml of ethanol/water mixture at 0-5° C. and dried under vacuum at 200 mbar, at 50-60° C. for 18 hr to furnish 31.0 g (i.e. a 71% yield) of product as fine white needles. A second crop of crystals (1.2 g, giving a total yield of 74%) was isolated from the mother liquors. The product was analysed by thin layer chromatography (one spot pure) and


1


H nmr which showed essentially clean product with trace impurities of triphenylphosphine oxide and DIAD-H2 (both estimated at <0.5%).




Example 2




The reaction scheme of Example 1 was followed but using a THF solvent instead of toluene.























Crude





100%










Chemical




Mass/Vol




Strength




Strength




MW




Moles




Molar Equiv




Source/Lot











2S, 3S,




100.0 g




97.7% LC




98.0 g




300




0.327




1.0×




Synthesised






chloroalcohol










according to













J. Org. Chem













1994,













59, 3656






THF




500 ml




>99%




500 ml




72














Petrochem













16/03 pre-













sample






TPP




103.8 g




99%




103.8 g




262




0.392




1.2×




PCL 00722






PNBA




66.1 g




>99%




65.6 g




167




0.392




1.2×




PCL 00728






DIAD




83.4 g




95%




79.2 g




202




0.392




1.2×




Schwizerhall













292-210-3288






Ethanol




600 ml




Absolute




600 ml




46














Shell 982437-






18






Water




600 ml




Towns




600 ml




18














Towns






Ethanol:water




2 × 500 ml




1:1




84 ml



















As above














Procedure




A 1L flange necked flask was equipped with an overhead mechanical stirrer (paddle), thermometer, pressure equalized dropping funnel and nitrogen blanket. The flask was charged with 2S, 3S Boc-chloroalcohol (100.0 g). THF (500ml) was added to form a slurry (KF 0.0805%). TPP (103.8 g) and PNBA (66.1 g) were sequentially added to the slurry and the slurry was stirred at 18-25C. DIAD (83.4 g) was dripped in via the dropping funnel over 20 min (4.2 g/min) maintaining the exotherm at 18-20C. On full addition, stirring was continued at between 18-20C for 2 hr when the slurry had dissolved up to an olive coloured solution. The solution was quenched into ethanol (600 ml) over 35 min (40 g/min) with stirring at 18-20C resulting in crystallization of product. The slurry was then stirred for 60 min at 5-10C. The slurry was filtered (54 μpaper), 150 mm diameter, vacuum 700 mbar, cake depth 40 mm, filtration time 14 m30 s) and the cake washed with 1:1 ethanol:water (2×500 ml). The solid was dried on the filter overnight to give 119 g of 14.5% KF solid, dry weight equivalent 102.3 g. 99.0% area % HPLC, 69% molar yield.




EXAMPLE 3




The esterified product of Example 1 or Example 2 was recrystallised as follows.




Reagents

























100%










Reagents




Mass




Strength




Strength




MW




Moles




Eq.




Source











2R, 3S




29.8 g




99%




29.7 g




449




0.0663




1.0×




From Example 1






Nitro ester





(assumed)






Ethanol




300 ml




Absolute




300 ml




85














Hays DEB 100






Water




80 ml




Towns




80 ml




18














Towns






Ethanol/water




100 ml




Absolute/




1:1



















Hays DEB 100/Towns








Towns














Procedure




A 1L flange necked flask was equipped with overhead mechanical stirrer (paddle) condenser, thermometer and nitrogen blanket The flask was charged with 29.8 g of ester and 300 ml of ethanol and heated to 70-75° C. until the ester was fully dissolved. Water was added in portions (causing turbidity) maintaining a temperature of >70° C. On full addition of the water the solution was heated for a further 10 min to give a pale yellow solution. The solution was cooled to 60° C., seeded with the product to induce crystallisation and slowly cooled to 10° C. over a period of 1 hr with the bulk of the product crystallising at 45-50° C. After stirring for 30 min at 10° C. the slurry was filtered through Whatman 54 paper and the cake was washed with 100ml of ethanol/water mixture at 0.5° C. and dried under vacuum at 50-60° C., 200 mbar for 18 hr to give 28.8 g (a 97% yield) of product as fine white needles. Thin layer chromatography analysis and


1


H nmr demonstrated that the ester was uncontaminated with triphenylphosphineoxide and DIAD-H2 impurities.




EXAMPLE 4




The recrystallised, esterified product from Example 3 was cyclised according to the following reaction scheme:











Reagents

























100%










Reagents




Mass




Strength




Strength




MW




Moles




Eq.




Source











2R, 3S Nitro




30.0 g




100%




30.0 g




449




0.0668




1.0×




Example 2






ester





(assumed)






Ethanol




1020 ml




Absolute




1020 ml




85














Hayman B100






KOH/water




125 ml




0.15 g/ml




18.8 g




40




0.47




7.0×




Aldrich













MS09811ES






Water




1000 ml




Towns




1000 ml




18














Towns






MDC




700 ml




LC grade




700 ml




92














Baker













9930020017






Citric acid




300 ml




5%




15.0 g




192




0.078









Plant






NaHCO


3






300 ml




5%




15.0 g




84




0.178









Aldrich













8116018






Water




300 ml




Towns




300 ml




18














Towns














Procedure




A 3L flange necked flask was equipped with an overhead mechanical stirrer (addle), thermometer, pressure equalised dropping funnel and nitrogen blanket. The flask was charged with 30.0 g of ester and 1020 ml of ethanol to form a slurry.




The slurry was cooled to 0-5° C. and 125 ml of KOH solution were added over a 5 min period maintaining the temperature at <5° C. On full addition the reaction was monitored by HPLC and was complete after 3 hr. The reaction was quenched with water (1000 ml), stirred for 5 min and extracted twice with MDC (once with 500 ml of MDC and then once with 200 ml of MDC). The combined organic extracts were washed with 300 ml of 5% citric acid, 300 ml of 5% NaHCO


3


and 300 ml of water. The product solution was dried in the presence of anhydrous sodium sulphate, filtered and concentrated on a rotary evaporator at 50° C. from 50-85 mbar to give 17.7 g (i.e. >95% yield) of a clear oil that slowly solidified on refrigeration, having a melting point of 49° C. The isolated product was >99% pure by area HPLC with no 2S,3S diastereomer observed.


1


H nmr of the product confirmed the structure.




EXAMPLES 5 to 14




The following table shows summary procedures and results of further esterification reactions according to the invention. Unless otherwise specified, the procedures and conditions were similar to those mentioned above in Example 1.























Input












Example




chloroalcohol




Scale




Reagent charge




Procedure




Work-up




Estimated Purity




Yield






























5




98.3% 2S, 3S




2.0 g




Toluene 70 ml




Add DEAD




Concentrate to oil then




98% (nmr)




78%







0.7% 2R, 3S





DEAD 1.2×




over 1 min then stir at




column chromatography









PPh


3


1.2×




20° C. for 2 hr









PNBA 1.2×






6




96.3% 2S, 3S




2.0 g




Toluene 100 ml




Add DIAD




Concentrate to oil then




98% (nmr)




82%







2.2% 2R, 3S





DIAD 1.2×




over 1 min then stir at




column chromatography









PPh


3


1.2×




20° C. for 2 hr









PNBA 1.2×






7




98.3% 2S, 3S




8.0 g




Toluene 250 ml




Add DEAD




Concentrate to oil, dissolve in




95% (nmr)




48%







0.7% 2R, 3S





DEAD 1.2×




over 1 min then stir at




ethanol (100 ml) then




Trace OPPh


3











PPh


3


1.2×




20° C. for 2 hr




crystallise









PNBA 1.2×






8




96.3% 2S, 3S




10.0 g




Toluene 250 ml




Add DIAD




Concentrate to oil, dissolve in




95% (nmr)




67%







2.2% 2R, 3S





DIAD 1.2×




over 5 min then stir at




ethanol (100 ml) then




Trace OPPh


3











PPh


3


1.2×




20° C. for 2 hr




crystallise (2 crops)









PNBA 1.2×






9




96.3% 2S, 3S




5.0 g




Toluene 200 ml




Add DIAD




Concentrate to oil, dissolve in




98% (nmr)




75%







2.2% 2R, 3S





DIAD 1.2×




over 5 min then stir at




ethanol (75 ml) then water




Trace OPPh


3











PPh


3


1.2×




20° C. for 2 hr




added (300 ml) at 70-80° C.,




DIAD-H2









PNBA 1.2×





cool and crystallise




contamination






10




96.9% 2S, 3S




30.0 g




Toluene 1200 ml




Add DIAD over 5 min




Concentrate to oil, dissolve in




98% (nmr)




67%







0.8% 2R, 3S





DIAD 1.2×




then stir at 20° C. for 2 hr




ethanol (450 ml) then water




Trace OPPh


3











PPh


3


1.2×





added (200 ml) at 70-80° C.,




DIAD-H2









PNBA 1.2×





cool and crystallise




contamination






11




98.8% 2S, 3S




60.0 g




Toluene 2400 ml




Add DIAD over 10 min




Concentrate to oil, dissolve in




98% (nmr)




74%







0.9% 2R, 3S





DIAD 1.2×




then stir at 20° C. for 2 hr




ethanol (900 ml) then water




Trace OPPh


3











PPh


3


1.2×





added (360 ml) at 70-80° C.,




DIAD-H2









PNBA 1.2×





cool and crystallise




contamination






12




97.8% 2S, 3S,




25.0 g




Dimethoxyethane




Add DIAD over 10 min




Add reaction mixture to




98% (nmr) Trace




72%







08.% 2R, 3S





250 ml DIAD




Then 2 hr stir it 20° C.




ethanol (200 ml) and water




OPPh3 and









1.4×, PPh3 1.4×,





(200 ml), filter resulting solid




DIAD-h2









PNBA 1.4×






contamination






13




97.7% 2S, 3S,




25.0 g




Tetrahydrofuran




Add DIAD over 20 min




Add reaction mixture to




90% (nmr)




68%







1.0% 2R, 3S





125 ml DIAD




Then 2 hr stir at 20° C.




ethanol (220 ml) and water




Residual TPPO









1.2×, PPh3 1.2×,





(300 ml), filter resulting solid









PNBA 1.2×






14




97.7% 2S, 3S 1.0%




100 g




Tetrahydrofuran




Add DIAD over 20 min




Add reaction mixture to




99.0% (HPLC)




69%







2R, 3S





500 ml DIAD




Then 2 hr stir at 20° C.




ethanol (600 ml) and water









1.2×, PPh3 1.2×,





(600 ml), filter resulting solid









PNBA 1.2×














EXAMPLES 15 to 17




The following table shows summary results of further examples of the recrystallisation step according to the invention. Unless otherwise specified, the procedures and conditions used are similar to those specified above in connection with Example 3.






















Example




Input Ester




Input Quality




Scale




Reagent Charge




Procedure




Estimated Purity




Yield











15




From Example 5




Trace OPPh


3






2.3 g




23 ml ethanol




Heat to dissolve,




Free of impurities




74%








and DEAD-H2






cool and filter.




by nmr








contamination






Thick mixture




CHN fits








by nmr






16




A blend




Trace OPPh


3






14.7 g




147 ml ethanol




Heat to dissolve,




Free of impurities




78%








and DEAD-H2






cool and filter.




by nmr








contamination






Thick mixture








by nmr






17




From Example 11




Trace OPPh


3






65.7 g




600 ml ethanol




Heat ester in




Free of impurities




95%








and DIAD-H2





160 ml water




ethanol to dissolve,




by nmr








contamination






then add water at








by nmr






70-75° C., cool and











filter














EXAMPLES 18 to 23




The following table shows in summary form further examples of the cyclisation step according to the invention. Unless otherwise specified, the procedures and conditions are similar to those specified above in connection with Example 4.






















Ex-













am-






ple




Input Ester




Scale




Reagent charge




Procedure




Work-up




Estimated Purity




Yield











18




Recrystallised




200 mg




Ethanol 25 ml




Add aqueous KOH to ethanol




Neutralise with citric acid and




>99%




79%







ester





KOH 30×




slurry of the ester. Monitor reaction




concentrate on RFE. Dissolve




2R, 3S by LC.










progress by LC. Complete after 1 hr




in MDC, acid base wash, dry




No 2S, 3S isomer










at




and concentrate to oil that




observed.










0-2° C.




solidifies on refrigeration




Pure by nmr






19




Recrystallised




5.0 g




Ethanol 200 ml




Add aqueous KOH to ethanol slurry




Neutralise with citric acid and




0.8% OPPh


3






88%







ester





KOH 7×




of the ester. Monitor reaction




concentrate on RFE. Dissolve




98.9% 2R, 3S










progress by LC. Complete after




in MDC, acid base wash, dry




0.2% alcohol










3.5 hr at 0-2° C.




and concentrate






20




Isolated ester




3.0 g




Isopropanol




Add aqueous KOH to slurry of the




Neutralise with citric acid and




7.6% imp




74%







from Example 9





120 ml




ester. Monitor reaction progress by




concentrate on RFE. Dissolve




82.4% 2R, 3S









KOH 5.0×




LC. Complete after 3.5 hr at 0-2° C.




in MDC, acid base wash, dry




9.52% imp











and concentrate






21




Recrystallised




3.0 g




Ethanol 120 ml




Add aqueous KOH to ethanol slurry




Neutralise with citric acid and




99.8% 2R, 3S




95%







ester from





KOH 7×




of the ester. Monitor reaction




concentrate on RFE. Dissolve




0.1% alcohol







Example 9






progress by LC. Complete after




in MDC, acid base wash, dry










3.5 hr at 0-2° C.




and concentrate






22




Recrystallised




25.0 g




Ethanol 1000 ml




Add aqueous KOH to ethanol slurry




Neutralise with citric acid and




0.4% 2S, 3S or




>95%







ester from





KOH 7× (105 ml)




of the ester. Monitor reaction




concentrate on RFE to half




OPPh


3









Example 17






progress by LC. Complete after 3 hr




volume. Dissolve in MDC,




99.6% 2R, 3S










at 0-2° C.




acid base wash, dry and











concentrate






23




Isolated ester




25.0 g




Ethanol 1000 ml




Add aqueous KOH to ethanol slurry




Neutralise with citric acid and




1.0% 2S, 3S or




>95%







from Example 10





KOH 7× (105 ml)




of the ester. Monitor reaction




concentrate on RFE to half




OPPh


3












progress by LC. Complete after 3 hr




volume. Dissolve in MDC,




99.6% 2R, 3S










at 0-2° C.




acid base wash, dry and











concentrate













Claims
  • 1. A process for producing an optically active (2R, 3S)-epoxide of the formula (1): or its enantiomer wherein each of R1 and R2 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, aryl, aralkyl, and alkaryl groups, and amine-protecting groups, and R3 is selected from hydrogen and optionally suitably protected alkyl, cycloalkyl, aryl, aralkyl and alkaryl groups, said process comprising subjecting an optically active (2S,3S)-alcohol offormula (2): or its enantiomer, wherein X is a leaving group, to a Mitsunobu reaction to obtain a Mitsunobu reaction product and cyclising the Mitsunobu reaction product to form an optically active (2R,3S) epoxide of the general formula (1), the stereochemistry of the optically-active (2S,3S)-alcohol or its enantiomer being inverted in said Mitsunobu reaction.
  • 2. The process of claim 1, further comprising recrystallising the Mitsunobu reaction product prior to cyclising.
  • 3. The process of claim 1 is wherein the compound of formula (2) is reacted with a phosphine and an azodicarboxylate under acid conditions to form an intermediate ester of formula (3): wherein R4 is an optionally nitrogenated alkyl, aryl, aralkyl or alkaryl group.
  • 4. The process of claim 2, wherein the compound of formula (2) is reacted with a phosphine and an azodicarboxylate under acid conditions to form an intermediate ester of formula (3): wherein R4 is an optionally nitrogenated alkyl, aryl, aralkyl or alkaryl group.
  • 5. The process of claim 3, wherein the phosphine comprises triphenylphosphine.
  • 6. The process of claim 3, wherein the azodicarboxylate is diisopropylazodicarboxylate.
  • 7. The process of claim 5, wherein the azodicarboxylate is diisopropylazodicarboxylate.
  • 8. The process of claim 3, wherein the acid conditions are provided by a carboxylic acid.
  • 9. The process of claim 5, wherein the acid conditions are provided by a carboxylic acid.
  • 10. The process of claim 6, wherein the acid conditions are provided by a carboxylic acid.
  • 11. The process of claim 8, wherein the carboxylic acid is paranitrobenzoic acid.
  • 12. The process of claim 1, wherein said Mitsonubo reaction takes places in the presence of a solvent comprising at least one of toluene and tetrahydrofuran.
  • 13. The process of claim 2, wherein said step of recrystallizing takes place in a recrystallizing solvent comprising ethanol and water.
  • 14. The process of claim 2, wherein said cyclization is effected by a base, following said step of recrystallizing.
  • 15. The process of claim 14, wherein said base comprises aqueous KOH and said cyclization takes place in ethanol.
  • 16. The process of claim 1, wherein said amine protecting group is butoxy/carbonyl.
  • 17. The process of claim 1, wherein said optically active (2S,3S)-alcohol is a haloalcohol.
Priority Claims (1)
Number Date Country Kind
0022772 Sep 2000 GB
PCT Information
Filing Document Filing Date Country Kind
PCT/GB01/04146 WO 00
Publishing Document Publishing Date Country Kind
WO02/24671 3/28/2002 WO A
Foreign Referenced Citations (6)
Number Date Country
0 657 446 Jun 1995 EP
1 029 856 Aug 2000 EP
1 029 856 Aug 2000 EP
09323960 Mar 1998 JP
WO 9938855 Aug 1999 WO
WO 0044736 Aug 2000 WO
Non-Patent Literature Citations (6)
Entry
Reference Supplied by Applicant.*
PCT International Search Report (PCT/GB 01/04146).
Aguilar, N. et al. “A Convergent, Stereocontrolled Synthesis of C2-Symmetrical and Pseudosymmetrical Sulfur-Tethered Bis (amino alcohols)” Tetrahedron Letters, NL., Elsevier Science Publishers, Amsterdam, vol. 40, No. 20, May 14, 1999, pp. 3913-3916, XP004163779; ISSN: 0040-4039.
Pegorier, L. et al. “A General Stereocontrolled Synthesis of Hydroxyethylene Dipeptide Isosteres” Tetrahedron Letters, NL, Elsevier Science Publishers, Amsterdam; vol. 36, No. 16, Apr. 17, 1995, pp. 2753-2756, XP004028345; ISSN: 0040-4039.
Beier C., et al.: “The First Asymmetric Synthesis of (1R.1′s)-1-(1′-(benzyloxy-carbonyl-methylamino)-2-'phenylethyl) oxirane: a promising building block for the synthesis of peptide mimics” Synlett., No. 1, Jan. 1998 (1998-01), pp. 41-42, XP002154607 Thieme Verlag, Stuttgart., De ISSN: 0936-5214.
O. Mitsunobu: “The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Systhesis and Transformation of Natural Products” Synthesis, De, George Thieme Verlag, Stuttgart, 1981, pp. 1-28; XP002123593; ISSN: 0039-7881.